INTERNATIONAL PATENT: TEVA PHARMACEUTICALS INTERNATIONAL GMBH FILES APPLICATION FOR "METHODS AND SYSTEMS FOR USING DIGITAL VOICE BIOMARKERS TO MONITOR SYMPTOMS OF SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDERS"

GENEVA, Nov. 10 -- TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Schlusselstrasse 128645 Jona) filed a patent application (PCT/EP2025/061973) for "METHODS AND SYSTEMS FOR USING DIGITAL VOICE BIOMARKERS TO MONITOR SYMPTOMS OF SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDERS" on Apr 30, 2025. With publication no. WO/2025/229131, the details related to the patent application was published on Nov 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GOTLER, Alex (Schlusselstrasse 128645 Jona), OREN, Ariel (Schlusselstrasse 128645 Jona)

Abstract: Systems and methods for assessing schizophrenia, for example ...